UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035217
Receipt number R000039593
Scientific Title H2FPEF Score for Identifying the High Risk Patients for Heart Failure-Related Events in Stable Outpatients with Cardiovascular Risk Factors
Date of disclosure of the study information 2018/12/17
Last modified on 2019/11/06 10:38:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

H2FPEF Score for Identifying the High Risk Patients for Heart Failure-Related Events in Stable Outpatients with Cardiovascular Risk Factors

Acronym

The association between H2FPEF Score and outpatients

Scientific Title

H2FPEF Score for Identifying the High Risk Patients for Heart Failure-Related Events in Stable Outpatients with Cardiovascular Risk Factors

Scientific Title:Acronym

The association between H2FPEF Score and outpatients

Region

Japan


Condition

Condition

Heart Failure related events

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess whether the H2FPEF score could identify the high risk patients for heart failure (HF) in stable outpatients with cardiovascular risk factor(s).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

HF-related event as a composite of cardiovascular death and hospitalization for HF decompensation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

stable outpatients with cardiovascular risk factor(s)

Key exclusion criteria

Left ventricular ejection fraction less than 50%
Severe valvular diseas
End stage of chronic kidney diseas including hemodialysis

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Kenichi
Middle name
Last name Tsujita

Organization

Graduate School of Medical Sciences, Kumamoto University

Division name

Department of Cardiovascular Medicine

Zip code

860-8556

Address

1-1-1 Honjo, Chuo-ku, Kumamoto City 860-8556, Japan

TEL

0963735175

Email

tsujita@kumamoto-u.ac.jp


Public contact

Name of contact person

1st name Satoru
Middle name
Last name SUZUKI

Organization

Graduate School of Medical Science,Kumamoto University

Division name

Department of Cardiovascular Medicine

Zip code

860-8556

Address

1-1-1 Honjo, Chuo-ku, Kumamoto City 860-8556, Japan

TEL

0963735175

Homepage URL


Email

s-satoru@kumamoto-u.ac.jp


Sponsor or person

Institute

Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

Kumamoto University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kumamoto University

Address

1-1-1 Honjo, Chuo-ku, Kumamoto City 860-8556, Japan

Tel

0963735175

Email

s-satoru@kumamoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 17 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-bin/ctr/ctr_up_reg_f5.cgi

Publication of results

Published


Result

URL related to results and publications

https://upload.umin.ac.jp/cgi-bin/ctr/ctr_up_reg_f5.cgi

Number of participants that the trial has enrolled

356

Results

The H2FPEF score could provide useful information for future HF-related events in stable outpatients with cardiovascular risk factor(s) in Japan.

Results date posted

2019 Year 11 Month 06 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Stable Japanese outpatients with at least 1 cardiovascular risk factor who were enrolled between September 2010 and July 2013, the 356 outpatients (171 men, 185 women, mean age 73.2 years) were eligible for the analysis.

Participant flow

Stable Japanese outpatients with at least 1 cardiovascular risk factor who were enrolled between September 2010 and July 2013, the 356 outpatients (171 men, 185 women, mean age 73.2 years) were eligible for the analysis.

Adverse events

Nothing.

Outcome measures

Heart Failure Event.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 09 Month 01 Day

Date of IRB

2018 Year 12 Month 03 Day

Anticipated trial start date

2010 Year 09 Month 01 Day

Last follow-up date

2013 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The patients have been followed-up regularly for the occurrence of cardiovascular event.


Management information

Registered date

2018 Year 12 Month 11 Day

Last modified on

2019 Year 11 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039593


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name